President Trump discusses FDA authorization of Convalescent Plasma

In effort to combat this pandemic, NuPlasma is working with Federal, State, and Local authorities to immediately commence a "convalescent plasma" collection and supply program. 

COVID-19 Donors

  • Once NuPlasma begins collections for our "convalescent plasma" program, we will actively be searching for RECOVERED COVID-19 patients.

  • Donors will be accepted according to all guidelines and requirements listed on the DONOR RESOURCES page.

  • To streamline the process, please bring COVID-19 confirmation test result documentation with you on your visit to our center.

  • Call ahead for an appointment.
    (512) 518-6262

Medical Professionals

  • The FDA has authorized the collection of COVID-19 convalescent plasma and its use for treating patients with COVID-19 under IND approval.

  • For requests that are not highly time sensitive (response from FDA provided within 4 to 8 hours), the requesting physician may contact FDA by completing Form 3926 and submitting the form by email to [email protected]

  • In the event of an emergency that is highly time sensitive (response required in less than 4 hours) or where the provider is unable to complete and submit form 3926 due to extenuating circumstances, the provider may contact FDA’s Office of Emergency Operations at 1-866-300-4374 to seek verbal authorization.

  • Physicians authorized to use convalescent plasma, please use the below contact form. 

Physician Contact Form
  • Facebook - Black Circle
  • Instagram - Black Circle


(512) 518-6262

© 2020 NuPlasma   - ALL RIGHTS RESERVED